This is the page subscribers use. The counts are the FDA record; the lists themselves, with every proceeding and document, are for subscribers.

Preview of Clinical Precedent (Disqualified and debarred). This is the page subscribers use. The counts are the FDA record; the lists themselves, with every proceeding and document, are for subscribers.

Enforcement

Disqualified and debarred

The two FDA actions that can end a clinical investigator’s eligibility — disqualification (a regulatory proceeding that starts with a NIDPOE letter and can bar a clinical investigator from receiving investigational products) and debarment (a statutory penalty tied to criminal conviction). Every proceeding on record, its outcome, and the underlying FDA documents where available.

Disqualification proceedings

A NIDPOE (Notice of Initiation of Disqualification Proceedings and Opportunity to Explain) opens the case; a NOOH (Notice of Opportunity for Hearing) escalates it; the status shows how it ended. Proceedings span all FDA centers — a disqualification bars the clinical investigator regardless of product type.

Status Find name

Clinical investigator	Center	Location	Status	Status date	NIDPOE	NOOH	Documents

Debarment list

Debarment under FD&C Act §306 follows a criminal conviction connected to drug products. It is a separate track from disqualification, and reaches beyond clinical investigators (pharmacists, executives, submission fraud) — but several clinical investigators appear on both lists. A person FDA has since taken off its list stays here, marked as no longer on it.

Name	Effective	Term	Status	Order

Matching caveat: these lists carry names only — no facility identifiers — so connecting a list entry to an inspection record is a name match. Same-name clinical investigators exist; confirm identity (location, specialty, dates) before acting on a match. Each clinical investigator link runs our vetting check under that name.